Literature DB >> 10656394

A clinical method for real-time dosimetric guidance of transperineal 125I prostate implants using interventional magnetic resonance imaging.

R A Cormack1, H Kooy, C M Tempany, A V D'Amico.   

Abstract

PURPOSE: The clinical utility of an interventional magnetic resonance (IMR)-guided implant technique with real-time dosimetric feedback is presented. METHODS AND MATERIALS: The work was carried out at a IMR unit at Brigham and Women's Hospital. Planning and dosimetric feedback were provided by a software system that provides an interface to the IMR images, anatomy demarcation, template registration, dose calculation engine for planning, and evaluating the implant. Planning during the procedure permits the incorporation of actual needle trajectories in the dose calculations.
RESULTS: Fifteen patients were planned in the treatment position. During source placement, actual needle locations were incorporated into the dose calculations. After accounting for the observed needle trajectories of the planned needles, 14 of 15 patients (93%) required additional sources to achieve the desired coverage of the target volume.
CONCLUSION: A brachytherapy implant procedure which provides clinically significant advances has been implemented. Specifically, the planning system allows dosimetric validation of the needle placement. This procedure is effective in delivering brachytherapy to the target volume and assuring that the implant is delivered in accordance with the preplan. The dosimetric feedback could be incorporated in ultrasound-guided implants.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10656394     DOI: 10.1016/s0360-3016(99)00422-8

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  9 in total

1.  Transrectal prostate biopsy and fiducial marker placement in a standard 1.5T magnetic resonance imaging scanner.

Authors:  Robert C Susil; Cynthia Ménard; Axel Krieger; Jonathan A Coleman; Kevin Camphausen; Peter Choyke; Gabor Fichtinger; Louis L Whitcomb; C Norman Coleman; Ergin Atalar
Journal:  J Urol       Date:  2006-01       Impact factor: 7.450

Review 2.  MR-guided prostate interventions.

Authors:  Clare Tempany; Sarah Straus; Nobuhiko Hata; Steven Haker
Journal:  J Magn Reson Imaging       Date:  2008-02       Impact factor: 4.813

3.  Open MR-guided high-dose-rate (HDR) prostate brachytherapy: feasibility and initial experiences open MR-guided high-dose-rate (HDR) prostate brachytherapy.

Authors:  Ferenc Lakosi; Gergely Antal; Csaba Vandulek; Arpad Kovacs; Gabor L Toller; Istvan Rakasz; Gabor Bajzik; Janaki Hadjiev; Peter Bogner; Imre Repa
Journal:  Pathol Oncol Res       Date:  2011-01-11       Impact factor: 3.201

4.  AAPM recommendations on dose prescription and reporting methods for permanent interstitial brachytherapy for prostate cancer: report of Task Group 137.

Authors:  Ravinder Nath; William S Bice; Wayne M Butler; Zhe Chen; Ali S Meigooni; Vrinda Narayana; Mark J Rivard; Yan Yu
Journal:  Med Phys       Date:  2009-11       Impact factor: 4.071

Review 5.  Permanent interstitial brachytherapy for prostate cancer: a current review.

Authors:  Jeffrey Woolsey; Nicole Miller; Dan Theodorescu
Journal:  World J Urol       Date:  2003-08-13       Impact factor: 4.226

6.  Development of an open source software module for enhanced visualization during MR-guided interstitial gynecologic brachytherapy.

Authors:  Xiaojun Chen; Jan Egger
Journal:  Springerplus       Date:  2014-03-31

Review 7.  Feasibility of functional imaging for brachytherapy.

Authors:  Alfredo Polo
Journal:  J Contemp Brachytherapy       Date:  2009-03-23

Review 8.  Image fusion techniques in permanent seed implantation.

Authors:  Alfredo Polo
Journal:  J Contemp Brachytherapy       Date:  2010-10-13

Review 9.  Trends in targeted prostate brachytherapy: from multiparametric MRI to nanomolecular radiosensitizers.

Authors:  Alexandru Mihai Nicolae; Niranjan Venugopal; Ananth Ravi
Journal:  Cancer Nanotechnol       Date:  2016-07-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.